Tissue Regenix makes first porcine tendon deliveries

Writer,

Regenerative medical devices company Tissue Regenix said it had notched first deliveries of its porcine tendon product, with additional shipments expected in early 2021.

The product, called OrthoPure was a decellularized porcine tendon and received CE Mark approval in June 2020 for the reconstruction of knee ligaments.

Tissue Regenix had in August announced its first distribution agreement, focused on the UK market, with a speciality supplier of orthopaedic and biologic products.

'The group has since targeted key European markets including securing an additional distribution partner in Poland,' it said.

'The group is currently engaged in a number of discussions with potential partners in other geographies.'


Related content

Tissue Regenix expects annual revenue to slip 2%

Regenerative medical devices company Tissue Regenix said it expected its annual revenue to slip 2%, in what it described as a 'strong' performance against a...

Mon, 08/02/2021 - 08:05


Tissue Regenix appoints CFO

Medical devices company Tissue Regenix has appointed David Cocke as CFO and director to the board with immediate effect.

Mr Cocke has over 29...

Thu, 21/01/2021 - 08:24


Tissue Regenix appoints Daniel Lee as CEO

Regenerative medical devices company Tissue Regenix said it had appointed Daniel Lee as chief executive.

Lee was currently the head of the company's US operations,...

Tue, 17/11/2020 - 08:50


Tissue Regenix losses narrow on cost cutting

Regenerative medical devices company Tissue Regenix posted a narrower first-half loss after it cut overheads.

Pre-tax losses for the six months through June amounted to...

Wed, 02/09/2020 - 07:47


Tissue Regenix enters UK distribution agreement for porcine tendon product

Regenerative medical devices company Tissue Regenix said it had entered into a distribution agreement and secured its first order with a speciality supplier of orthopaedic...

Mon, 24/08/2020 - 07:50